Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Current Colorectal Cancer Reports|March 6, 2012
Epigenetics Offer New Horizons for Colorectal Cancer PreventionMichael Schnekenburger, Marc DiederichEpigenomics|December 1, 2011
Conference Scene: Omic technologies in human disease: extending the network of epigenetic controlMichael Schnekenburger, Marc DiederichFrontiers in Pharmacology|August 1, 2014
Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosisMichael Schnekenburger, Tommy Karius, Marc DiederichCurrent Topics in Medicinal Chemistry|August 26, 2015
Role of Histone Acetylation in Cell Cycle RegulationMiglena Koprinarova, Michael Schnekenburger, Marc DiederichBiochimica Et Biophysica Acta|August 21, 2007
HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activationMichael Schnekenburger, Li Peng, Alvaro PugaCancer Letters|June 26, 2014
Epigenetic modulators from "The Big Blue": a treasure to fight against cancerMichael Schnekenburger, Mario Dicato, Marc DiederichMolecular and Cellular Biology|August 8, 2007
Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activationMichael Schnekenburger, Glenn Talaska, Alvaro PugaBiotechnology Advances|April 5, 2014
Plant-derived epigenetic modulators for cancer treatment and preventionMichael Schnekenburger, Mario Dicato, Marc DiederichCancer|March 7, 2019
Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?Michael Schnekenburger, Mario Dicato, Marc F DiederichToxicological Sciences : an Official Journal of the Society of Toxicology|February 5, 2011
Aryl hydrocarbon receptor ligands of widely different toxic equivalency factors induce similar histone marks in target gene chromatinJerald L Ovesen, Michael Schnekenburger, Alvaro PugaPageof 7